Baird lowered the firm’s price target on Healthpeak Properties (DOC) to $22 from $24 and keeps an Outperform rating on the shares. The firm updated its model following Q1 results where it appears the copany’s allocation will shift back to stock buybacks.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOC:
- Healthpeak Properties Approves Employee Stock Purchase Plan
- Healthpeak Properties price target lowered to $22 from $24 at Wedbush
- Healthpeak Properties Reports Strong Q1 2025 Results
- Healthpeak Properties’ Earnings Call Highlights Resilience Amid Challenges
- Healthpeak Properties: Strong Business Growth and Strategic Financial Moves Justify Buy Rating